It suggested that AR-overexpression could block out the effect of MTNR1A, and AR acted as an important downstream factor of MTNR1A in aromatase production, thus playing a vital role in the PCOS-related pathophysiological process of androgen excess. Here, CYP19A1 is linked to polycystic ovary syndrome.